Y-mAbs Therapeutics
YMAB
#8047
Rank
โ‚ฌ0.18 B
Marketcap
4,15ย โ‚ฌ
Share price
-2.58%
Change (1 day)
-68.83%
Change (1 year)

Earnings for Y-mAbs Therapeutics (YMAB)

Earnings in 2024 (TTM): -โ‚ฌ28.91 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ87.68 Million. a decrease over its 2023 earnings that were of -โ‚ฌ23.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Y-mAbs Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ28.51 Million21.54%
2023 -โ‚ฌ23.46 Million-72.92%
2022 -โ‚ฌ86.61 Million77.47%
2021 -โ‚ฌ48.81 Million-55.46%
2020 -โ‚ฌ0.11 Billion44.49%
2019 -โ‚ฌ75.83 Million92.01%
2018 -โ‚ฌ39.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.14 Billion 357.98%๐Ÿ‡บ๐Ÿ‡ธ USA